©Author(s) (or their employer(s)) 2026.
World J Gastroenterol. Mar 14, 2026; 32(10): 115334
Published online Mar 14, 2026. doi: 10.3748/wjg.v32.i10.115334
Published online Mar 14, 2026. doi: 10.3748/wjg.v32.i10.115334
Figure 2 Network pharmacology analysis.
A: Venn analysis; B: Protein-protein interaction topology analysis; C: Component-disease-target network diagram; D: Kyoto Encyclopedia of Genes and Genomes enrichment analysis. HDI: Hedyotis diffusa injection; HIF: Hypoxia inducible factor.
- Citation: Xia SW, Liu H, Yang KY, Gao YJ, Zhang MR, Zhou JW, Kong DS, Wu HY, Zhang F, Chen L. Integrative study reveals NR1D1 mediates Hedyotis diffusa’s antifibrosis via hypoxia inducible factor-1/ammonia axis. World J Gastroenterol 2026; 32(10): 115334
- URL: https://www.wjgnet.com/1007-9327/full/v32/i10/115334.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i10.115334